Morgan Waller Scott

How Products Targeting Women’s Iron Deficiency and Anemia Can Outperform in the Market The women’s health space—especially around #anemia and iron deficiency—is no longer just a gap. It’s a $360 billion opportunity for innovation, education, and market leadership. We’re helping brands unlock that potential by introducing the Anemia Insignia, a symbol designed to bridge the critical 30% gap in provider–patient trust, communication, and visibility. When placed on products, it signals credibility, compassion, and a commitment to underserved needs. — But we’re not stopping there. Through Patient Blood Management (#PBM) integration and our Regular Self Monitoring (#RSM) initiative, we’re shifting awareness from reactive to proactive—empowering women to track, manage, and own their health outcomes. — Backed by strategic storytelling and our expanding social media presence, we give the Anemia Insignia the spotlight it deserves—positioning it not just as a symbol, but as a movement. Let’s build together where care, innovation, and awareness meet. Because when we support women’s health, we don’t just fill a gap—we change the game. #WomensHealth #AnemiaAwareness #IronDeficiency #PatientBloodManagement #RegularSelfMonitoring #HealthEquity #HealthcareInnovation #FemTech #TrustDrivenBranding #RSM

4

1 Comment

🩸 PBM+ | Global Acronym vs. Symbol — which truly engages the public? For years, "PBM" (Patient Blood Management) has been a clinical acronym familiar to medical professionals. But familiarity doesn’t equal engagement. The public remains unaware. Confused. Disconnected. Then came PBM+™ — a unified global symbol designed to close the gap between clinical strategy and public understanding. As this AI-powered forecast reveals: 🔹 The acronym is growing slowly. 🔴 The symbol is accelerating rapidly — and becoming the public face of a vital movement in global health. Backed by the World Health Organization’s guidelines and strengthened by public trust, PBM+ is doing what acronyms can’t: → Creating visibility → Driving patient-centered awareness → Inspiring equity across healthcare systems The data is clear. The symbol works. 💡 It's time for global health leaders, pharma, hospitals, and organizations to choose to help shape the next era of patient care. #PBMPlus #PBM #PatientBloodManagement #GlobalHealth #HealthEquity #WHO #HealthcareCommunication #AIHealthcare #SymbolPower #EngagementMatters #BloodManagement

2

Now you know where patients stand. The irony is hard to ignore: Patient Blood Management rarely puts the patient first. According to our AI-generated analysis, patients are perceived as having the least ownership or influence in PBM—behind clinicians and industry innovators. The very acronym was meant to protect them, but somewhere along the way, their voice was lost. Patients needed their own identity. That’s why we created the #PBM+ symbol—the first and only universal mark designed to give patients visibility, identity, and protection in the global PBM conversation. This symbol isn’t just about recognition. It’s about restoring balance and reclaiming the patient’s rightful place at the center of care. If you're aligned with our mission to make the patient the priority, then now is the time to partner. Because the future of Patient Blood Management must finally start with the patient.

3

𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: 𝗠𝗲𝗱𝗖𝗼𝗺𝗺𝘀 In this week’s medical communications post, we discuss three of the latest insights in the world of #MedComms. 𝗘𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗻𝗴 𝗸𝗲𝘆 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗶𝗻𝗱𝗶𝗰𝗮𝘁𝗼𝗿𝘀 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗺𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 In a recent interview on NetworkPharma.tv, Dan Buckland, Director at Brandcast Health, discusses the importance of strategic thinking when assessing key performance indicators (KPIs) in healthcare marketing. He advises focusing on two core performance indicators: conversion rate and cost per conversion. According to Buckland, these two KPIs most effectively reflect the return on investment of marketing campaigns. He cautions against considering an overwhelmingly large number of KPIs. He also suggests not relying heavily on engagement metrics such as impressions or likes, which may not translate into meaningful behaviour changes. Interview Link: https://shorturl.at/0BHdy Dan Buckland LinkedIn: https://shorturl.at/tkD19 𝗨𝘀𝗶𝗻𝗴 𝗔𝗜 𝘁𝗼𝗼𝗹𝘀 𝗳𝗼𝗿 𝗺𝗮𝗻𝘂𝘀𝗰𝗿𝗶𝗽𝘁 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 The recently published edition of the International Society for Medical Publication Professionals (ISMPP) Newsletter revealed the results of a poll on the role of AI (artificial intelligence) in scientific writing. The poll included answers from 95 respondents active in research. Over 60% of the respondents expressed interest in using AI tools for manuscript development. However, many also showed concern regarding data integrity, ethical use, transparency and authorship challenges. The article underlines that human expertise remains vital for scientific accuracy and integrity. Article Link: https://shorturl.at/1P5mX 𝗛𝗼𝘄 𝘁𝗼 𝗮𝘃𝗼𝗶𝗱 𝗰𝗼𝗺𝗺𝗼𝗻 𝘀𝘁𝘆𝗹𝗲 𝗲𝗿𝗿𝗼𝗿𝘀 𝗶𝗻 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝘄𝗿𝗶𝘁𝗶𝗻𝗴 The American Medical Writers Association (AMWA) recently published a blog addressing common medical style mistakes and how to avoid them. The blog discusses typical issues such as inconsistent terminology, improper abbreviations and misuse of eponyms. One of the key messages from the blog was the importance of adhering to a defined style guide –⁠ such as the AMA Manual of Style –⁠ to ensure consistency and credibility. According to the blog, custom checklists, style software and revisions of editorial standards can help medical writers improve content clarity and build reader trust. AMWA Blog Article Link: https://shorturl.at/D0GLd AMA Style Manual: https://shorturl.at/rNTjx For more industry insights visit elion.nz/insights/ #MedicalWriting #HealthcareMarketing #AIinHealthcare #ScientificPublishing #MedicalEducation #Elion

5

Healthcare marketing leaders are being asked to deliver more. But the real challenge isn't the work. It's the conversations behind it. Growth. Resources. Measurement. In our latest piece, Shannon Curran breaks down the three conversations every healthcare marketing leader should be having with their C-suite — and why getting aligned on these changes everything. Read the full article at https://hubs.li/Q03_TFZT0 #HealthcareMarketing #MarketingLeadership #HealthSystemMarketing #UnlockHealth

20

Great insight from my 3D colleagues on how sponsors should navigate the drug approval process under the current administration. With less advisory committee meetings and less transparency, it’s critical to seek earlier opportunities in the review process to involve expert and patient perspectives.

1

Diane Brady from #Fortune spoke with #symplr CEO BJ Schaknowski about the urgent need to support #nurses and the role of technology in improving #healthcare. As BJ shared, "We’re not going to create millions more nurses overnight. We need to make the ones we have more productive." With #AI and smarter tech solutions, we can give nurses back precious time, reduce paperwork, and ultimately improve patient care. Read more about the conversation here: https://lnkd.in/ePvUmdGC #FutureOfNursing

5

An interactive session at TrialScope EXTRA 2025 on “Benchmarking Disclosure Performance” featured Citeline Senior Solution Consultant Brian Kuzich and Principal Project Manager Sahil Khatter. They asked attendees what their organizations considers standard disclosure benchmarks, such as: regulatory compliance (FDA, EMA, Health Canada etc), use of the Good Pharma Scorecard criteria as a guide, FDAAA Trial Tracker or EU Trials Tracker). #TrialScopeEXTRA2025 #ClinicalTrialDisclosure #ClinicalTransparency

28

1 Comment

Kudos to Kim for speaking up and out for the critical role good comms play in corporate success. Another data point is the overwhelming majority of buy side investors who when polled say that good communication enhances shareholder value. The problem is often one of P&L categories. Comms and IR teams are staff and not line functions. So it’s hard to quantify the value. But we all know it when we see it.

11

Wonderful gathering of incredible communications leaders, getting real about what it takes to communicate with clarity. One of the common threads: thoughtful assessment and adaptability. How are stakeholders shifting? Are all the right communications elements fully dialed in? Is there a better, more high impact path to consider? It was a good reminder of why I love working in communications. We also shared insights from our latest Brands in Motion study, developed with Ipsos, which underscores the importance of staying tuned in and adaptable. The research explores how expectations are shifting—and what audiences need most right now. Spoiler: It’s not perfection. It’s honesty, action, and the courage to evolve. #WeBrandsInMotion #Communications #Leadership #Adaptability 

24

1 Comment

Pretty much every digital health vendor now claims to be "AI-powered," but how do you cut through the marketing noise to find solutions that actually deliver? I chatted with Dr. Anand Rao, PhD, MBA and Sundar Subramanian to find out. Here are some of the strategies they shared with me: -- Start with the problem, not the technology. Don't ask "Where can I plug AI?" Instead, identify your specific outcome first, then determine if AI can help achieve it. -- Understand what's under the hood. Ask vendors about their underlying AI technology. Is it traditional predictive modeling, generative AI or multi-agent systems? Each serves a different purpose. -- Demand proof, not promises. Request real-world case studies, performance metrics and detailed explanations beyond flashy marketing materials. As Dr. Rao noted: "Just because we've got LLMs, we don't have to ditch all the things that are currently working." Read the full article: https://lnkd.in/gPV7Qycz #HealthcareAI #DigitalHealth #HealthTech #ArtificialIntelligence #HealthcareLeadership

18

What’s the future of healthcare PR? It’s here, and it’s being shaped by AI-powered insights, data-driven storytelling, and digital-first communications. Our latest article breaks down how forward-thinking organizations can stay credible, connected, and visible in this fast-changing landscape. Read now: https://loom.ly/lvAYy7k #HealthcarePR #HealthcarePRAgency #HealthcareCommunications #AIinHealthcare #DigitalStorytelling #AIinCommunications #PublicRelations #RosicaCommunications

3

Medical Affairs teams are under more pressure than ever—and your MedComms agency should be helping, not just handing over deliverables. In our latest piece, Wesley Portegies outlines what pharma teams should really expect from their agency partners today: strategic thinking, scientific fluency, digital savvy, and a whole lot more. If your agency isn’t helping you influence stakeholders or think more clearly, it might be time to raise the bar. Here's what to look for 👉 🔗 https://lnkd.in/dnSEZcry #MedicalAffairs #MedComms #PharmaMarketing #StrategicPartnership #ThoughtLeadership #OmnichannelEngagement

19

Innovation in pharmacy compounding is accelerating, and leading health systems are stepping forward with bold, collaborative solutions. Premier’s work with STAQ Pharma, Prisma Health and University Hospitals shows how transparency, data-driven insights and shared expertise can transform operations and elevate patient care. Learn how these three partners are redefining what’s possible in compounding. Read more here: https://lnkd.in/et2at9Vk

6

Check out our recent blog post on how #AI is transforming #healthcare - and the critical role #comms and #marketing can play in shaping the narrative. AI is already improving #diagnostics, #patient care and healthcare operations, but with so much hype (and skepticism) in the air, it’s up to #communications leaders to make complex topics easy to understand and credible. Key takeaways for comms teams including: - Position AI as a partner to clinicians, not a replacement - Prioritise trust, ethics, and transparency in every message - Bring the human impact to life through stories, not specs - Help brands speak with authority without overpromising Check out the full article here: https://lnkd.in/gNsqHPtp #healthcarecomms #AI #healthtech #futureofhealthcare #strategiccomms #Brands2Life

9

Small clinical teams don’t fail at S&OP from missing systems...they fail from unclear demand and decisions. In this newly published article, Tom Walls discusses how alignment comes from discipline, shared visibility, and acting on reality before timelines slip. https://bit.ly/4q2swkk #lifesciences #clinicaltrials #supplychainexcellence

7